CG
CLDX icon

Caprock Group’s Celldex Therapeutics CLDX Stock Holding History

Caprock Group’s Portfolio CLDX Stock Details CLDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-904
Closed -$32K – 450
2018
Q1 		$32K Buy
+904
New +$32K 0.01% 443